REQUEST A DEMO
Total
USD $0.00
Search more companies

Innopharm S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Innopharm S.A. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Innopharm S.A. is a company based in Ecuador, with its head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 15, 2016. There are currently 15 (2023) people employed by Innopharm S.A.. From the latest financial highlights, Innopharm S.A. reported a net sales revenue increase of 4.17% in 2023. Its’ total assets recorded a growth of 27.04%. The net profit margin of Innopharm S.A. increased by 0.46% in 2023.

Headquarters
Av Eugenio Espejo 24-10, Centro C Plaza del Rancho Bldg. , Floor 40
Quito; Pichincha;

Contact Details: Purchase the Innopharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Innopharm S.A. report to view the information.
Outstanding Shares:
Purchase the Innopharm S.A. report to view the information.
Registered Capital:
Purchase the Innopharm S.A. report to view the information.
Incorporation Date:
March 15, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
20%
Purchase this report to view the information.
15%
Purchase this report to view the information.
14%
Company Performance
Financial values in the chart are available after Innopharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.17%
Total operating revenue
4.62%
Operating profit (EBIT)
-87.78%
EBITDA
-86.54%
Net Profit (Loss) for the Period
45.15%
Total assets
27.04%
Total equity
7.94%
Operating Profit Margin (ROS)
-41.02%
Net Profit Margin
0.46%
Return on Equity (ROE)
1.88%
Quick Ratio
-0.11%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?